David Issott
Partner at Hg


David is a partner and focusses on Hg’s Mercury fund and healthcare technology cluster. He sits on the firm’s Realisation Committee and the Investment Committee for the Mercury fund.

David has worked in private equity since 2004 and joined Hg in 2012. David currently sits on the boards of Allocate Software, Evaluate, Rhapsody and Trace One. He was previously involved with Hg’s investments in Commify, Orion Healthier Populations, Relay and Valueworks.

David joined from Apax Partners where he worked in both their London and New York offices. Prior to Apax, he worked in investment banking at Lazard and as a management consultant at LEK Consulting.

David holds a first class Masters degree from Oxford University.


David's Insights

Healthcare Tech: Bending the “cost vs care” curve
Vive la révolution: HealthInvestor UK interviews Hg's David Issott
Healthcare Technology: A “Mid-Office Revolution”